Research programme: methionine aminopeptidase-2 inhibitors - Abbott

Drug Profile

Research programme: methionine aminopeptidase-2 inhibitors - Abbott

Alternative Names: A-357300; A-772561; A-773575; A-778728; A-800141; Methionine aminopeptidase-2 inhibitors research programme - Abbott

Latest Information Update: 23 Jan 2013

Price : $50

At a glance

  • Originator Abbott Laboratories
  • Class Small molecules
  • Mechanism of Action Aminopeptidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 23 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
  • 30 Mar 2010 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 04 Sep 2006 A preclinical study has been added to the Cancer pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top